Social and Behavioral Challenges of HIV Vaccines: Implications for Social Work and Social Science

作者: Peter A. Newman

DOI: 10.1080/15381500903396857

关键词:

摘要: A safe and efficacious HIV vaccine would be a tremendous asset to halting the spread of HIV. Nevertheless, vaccines face range social behavioral challenges that will determine their ultimate contribution prevention. development clinical trials raise thorny social, behavioral, ethical issues around resource allocation, recruitment enrollment, trial implementation, post-trial follow-up access services. Furthermore, success future is contingent on acceptability. Involvement work service providers engagement science research across continuum dissemination are central successful community advocacy, mitigation harms trials, support for fair conduct acceptability vaccines, integration with

参考文章(69)
Theresa Diaz, Susan Y. Chu, James W. Buehler, Denise Boyd, Patricia J. Checko, Lisa Conti, Arthur J. Davidson, Pat Hermann, Mary Herr, Anna Levy, Anne Shields, Frank Sorvillo, Eve Mokotoff, Bruce Whyte, Bradley S. Hersh, Socioeconomic Differences Among People with AIDS: Results from a Multistate Surveillance Project American Journal of Preventive Medicine. ,vol. 10, pp. 217- 222 ,(1994) , 10.1016/S0749-3797(18)30594-4
A. R. Gable, S. W. Lagakos, Methodological challenges in biomedical HIV prevention trials. Methodological challenges in biomedical HIV prevention trials.. ,(2008)
J. Cohen, Vaccine Results Lose Significance Under Scrutiny Science. ,vol. 299, pp. 1495- 1495 ,(2003) , 10.1126/SCIENCE.299.5612.1495
I Wolffers, None, Biomedical and development paradigms in AIDS prevention Bulletin of The World Health Organization. ,vol. 78, pp. 267- 273 ,(2000) , 10.1590/S0042-96862000000200017
Margaret A. Chesney, Donald B. Chambers, James O. Kahn, Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note. Journal of Acquired Immune Deficiency Syndromes. ,vol. 16, pp. 266- 271 ,(1997) , 10.1097/00042560-199712010-00007
Nicole Crepaz, Trevor A. Hart, Gary Marks, Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA. ,vol. 292, pp. 224- 236 ,(2004) , 10.1001/JAMA.292.2.224
Michael M Cassell, Daniel T Halperin, James D Shelton, David Stanton, Risk compensation: the Achilles' heel of innovations in HIV prevention? BMJ. ,vol. 332, pp. 605- 607 ,(2006) , 10.1136/BMJ.332.7541.605
Deborah A Gust, Ryan E Wiegand, Michael Para, Robert T Chen, Brad N Bartholow, HIV testing outside of the study among men who have sex with men participating in an HIV vaccine efficacy trial. Journal of Acquired Immune Deficiency Syndromes. ,vol. 52, pp. 294- 298 ,(2009) , 10.1097/QAI.0B013E3181AB6E93
Susan P. Buchbinder, Barbara Metch, Sarah E. Holte, Susan Scheer, Anne Coletti, Eric Vittinghoff, Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. Journal of Acquired Immune Deficiency Syndromes. ,vol. 36, pp. 604- 612 ,(2004) , 10.1097/00126334-200405010-00009
Neal Dickert, Ezekiel Emanuel, Christine Grady, Paying Research Subjects: An Analysis of Current Policies Annals of Internal Medicine. ,vol. 136, pp. 368- 373 ,(2002) , 10.7326/0003-4819-136-5-200203050-00009